Lasa Supergenerics Limited — Board Meeting, 05-08-2025: Outcome of Board Meeting

Lasa Supergenerics' board has approved the appointment of four new Independent Directors: Mr. Ketan Bhau Songal, Mr. Pravin Gadalya Lachake, Mr. Yogesh Hari Ughada, and Mrs. Rekha Hemant Wakh. Each will serve a five-year term, subject to shareholder approval. Their combined expertise in agro-veterinary sciences, poultry operations, and animal nutrition significantly bolsters the board's strategic capabilities in Lasa's core business segments. This move is poised to enhance governance and strategic direction.